PORTAGE, Mich., USA, June 4, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive1, modern platform to help advance patient care.
Emergency responders and healthcare professionals are facing unprecedented challenges and staff shortages. Seventy-five percent of healthcare workers face mental health struggles such as burnout, stress and anxiety.2 First responders and healthcare providers work in a demanding, fast-paced environment and providing them with advanced technology can help streamline efficiencies. The LIFEPAK 35 is a connected solution giving life-saving teams real-time access to crucial patient information3, supporting their needs while enhancing patient care4,5,6.
"After more than 10 years of research, coupled with feedback from hundreds of our customers around the globe, we're excited to offer first responders and essential healthcare professionals an innovative monitor/defibrillator in a familiar, trusted platform," said Anne Mullally, vice president and general manager of Stryker's Emergency Care business. "By enabling more efficient workflow and providing clinical advancements with LIFEPAK 35, we are proud to support the challenges these providers face in our communities."
Built on a legacy of life-saving products and designed for today's modern healthcare professional, the LIFEPAK 35 platform offers a slim, light, ergonomical design with a large intuitive touch screen to provide a customizable clinical experience. The LIFEPAK 35 allows trend monitoring to help guide caregiver decisions with its configurable events and connected capabilities for patient data, helping to support advanced patient care.3 To learn more about LIFEPAK 35, please visit our website.
To learn more about our smart, connected digital solutions and how we are making healthcare better, please visit http://stryker.com/AdvancedDigitalHealthcare.
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
Media contact
Meghan Menz
Sr. Director, Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$359.17 |
Daily Change: | -11.64 -3.14 |
Daily Volume: | 1,548,722 |
Market Cap: | US$136.920B |
November 19, 2024 November 14, 2024 October 29, 2024 September 20, 2024 September 17, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB